Just caught Profound Medical's Q4 earnings and the growth is pretty solid. Revenue jumped 43% year-over-year to hit $5.97M, and their bottom line more than held its own at $8.17M compared to $4.94M last year. Per-share earnings went from $0.20 to $0.27, so shareholders definitely seeing some upside there.

What's interesting is how consistent the momentum looks. That kind of top-line acceleration usually signals something's working in their operations. The profound improvement in profitability relative to revenue growth suggests they're getting more efficient too, not just chasing bigger sales numbers.

For a medical device play, these numbers aren't bad at all. Worth keeping on the radar if you're looking at healthcare sector moves.